To examine whether the effects of SESN2 overexpression and IR treatment, leading to inhibition of the Akt signaling pathway, influence cancer cell survival after IR, a clonogenic survival assay using radiation doses (0–8Gy) was conducted (Figure 4C). The gene discussed is SESN2; the disease is cancer.